Results 191 to 200 of about 1,205,127 (273)

Flexible dose of semaglutide reduces early discontinuation while maintaining comparable outcomes in obese patients: FLEX‐SEMA 2.4 mg, an Italian real‐world study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate real‐world clinical use of semaglutide in obese patients, focusing on titration, tolerability and short‐term efficacy. Materials and Methods This retrospective study included obese patients treated with the weekly injectable semaglutide.
Simone Pampanelli   +12 more
wiley   +1 more source

Effectiveness of behavioural economics‐based financial incentives and social feedback on glycaemic control and physical activity in adults with newly diagnosed type 2 diabetes: A randomised control trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the effectiveness of behavioural economics‐based financial incentive and social comparison feedback in adults with newly diagnosed type 2 diabetes. Materials and Methods We conducted a pragmatic randomised control trial with 6‐month intervention and 3‐month post‐intervention follow‐up.
Cheryl W. Y. Lai   +14 more
wiley   +1 more source

Comparability of Liquid Chromatography Tandem Mass Spectrometry Analysis of Dissolved Organic Matter across Laboratories. [PDF]

open access: yesEnviron Sci Technol
Kalinski JC   +50 more
europepmc   +1 more source

Early versus late initiation of long‐acting insulin in paediatric and adult diabetic ketoacidosis: A systematic review and meta‐analysis of randomised control trials

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetic ketoacidosis (DKA) is a serious complication of diabetes, requiring intravenous (IV) insulin until resolution and subsequent transition to subcutaneous insulin. Currently, clinical guidelines vary regarding the timing of long‐acting subcutaneous insulin initiation, with some advocating early administration during IV insulin ...
Bachviet Nguyen   +4 more
wiley   +1 more source

Microbial synthesis structures organic compound composition in anaerobic digestion. [PDF]

open access: yesISME J
Yang X   +12 more
europepmc   +1 more source

Providing holistic care for patients with metabolic dysfunction‐associated steatotic liver disease/metabolic dysfunction‐associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD), characterised by hepatic steatosis and metabolic dysfunction (i.e., obesity, type 2 diabetes, dyslipidaemia, and hypertension), is affecting over 30% of the adult population worldwide.
Lanlan Chen, Paul Horn, Frank Tacke
wiley   +1 more source

The emergence of nitrification during DOM processing by marine microbial assemblages. [PDF]

open access: yesPLoS One
Flynn KJ   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy